Drug Profile
Oxyntomodulin long-acting - Pharmsynthez/Xenetic Biosciences
Alternative Names: Oxyntolong; PSA-oxyntomodulinLatest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Pharmsynthez; Xenetic Biosciences
- Developer Pharmsynthez
- Class Anorectics; Antihyperglycaemics; Gastrointestinal hormones; Obesity therapies; Peptides
- Mechanism of Action Glucagon like peptide 1 receptor agonists; Glucagon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Obesity; Type 2 diabetes mellitus